<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">&quot;Autoimmune Epilepsy&quot;: Encephalitis With Autoantibodies for Epileptologists</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Christian</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
							<email>christian.bien@gmx.de</email>
							<affiliation key="aff0">
								<orgName type="department">Epilepsy Centre Bethel</orgName>
								<address>
									<addrLine>Krankenhaus Mara</addrLine>
									<settlement>Bielefeld</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Address correspondance to Christian G. Bien</orgName>
								<address>
									<addrLine>Epilepsy Centre Bethel, Krankenhaus Mara, Maraweg 17-21</addrLine>
									<postCode>33649</postCode>
									<settlement>Bielefeld</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Holtkamp</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Epilepsy-Center</orgName>
								<orgName type="department" key="dep2">Department of Neurology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin-Brandenburg, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">&quot;Autoimmune Epilepsy&quot;: Encephalitis With Autoantibodies for Epileptologists</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">BF180567FCB778109B855335860FC440</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:17+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Autoimmune encephalitides may account for epilepsies of so far unknown cause.</s><s>These "autoimmune epilepsies" may respond well to immunotherapy.</s><s>More than a dozen autoantibodies have been found with this constellation; therefore, broad autoantibody testing of serum-CSF pairs offers the best diagnostic yield.</s><s>Several particular features raise the suspicion of an autoimmune cause in otherwise unexplained seizure disorders.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Commentary</head><p><s>One of the most important challenges of scientific and clinical epileptology is the elucidation of the causes of seizure disorders: in a general sense and on the individual patient level.</s><s>In recent years, neuroimmunology has contributed to these efforts by identifying immunoglobulin G (IgG) antibodies against neural antigens in patients with so far unrecognized autoimmune encephalitides, which often lead to recurrent seizures.</s><s>This review article does not try to give a comprehensive review of what has been achieved in this field.</s><s>The authors of this review article, two neurologists with long-lasting expertise in clinical epileptology, one of whom has particular interest in the diagnosis of neural antibodies, try to give a clinically meaningful overview and useful management suggestions for autoimmune encephalitides with predominant epileptic features, that is, the "autoimmune epilepsies" <ref type="bibr" target="#b0">(1)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Some Basic Facts</head><p><s>In the first decade of this century, IgG autoantibodies against proteins on the surfaces of neurons were identified as markers and pathogens in autoimmune encephalitides that in approximately 80% of cases are accompanied by repetitive focal seizures <ref type="bibr" target="#b0">(1)</ref>.</s><s>Apart from those surface targets, intracellular antigens (most of them first identified in the 1980s and 1990s) account for a relevant, albeit smaller number of antibody associated encephalitides: the onconeural antibodies-those potentially occurring with seizures are directed against Hu, Ma, CV2, amphiphysin, Delta/Notch-like EGF-related receptor (previously: Tr) , or Sox1 and those against glutamic acid decarboxylase (GAD).</s><s>For an overview of autoantibodies with epileptologic relevance, see Figure <ref type="figure" target="#fig_0">1</ref>.</s></p><p><s>From an epileptologic viewpoint, a highlight was the discovery of a new seizure type, faciobrachial dystonic seizures (FBDS), by a team of neuroimmunologists and epileptologists based on the demonstration of antibodies against the voltagegated potassium channel (VGKC) complex; the antigenic target was later identified as Leucine-rich, glioma inactivated 1 (LGI1) <ref type="bibr" target="#b1">(2,</ref><ref type="bibr" target="#b2">3)</ref>, an element of the VGKC complex.</s></p><p><s>The pathophysiology of antibody-defined autoimmune encephalitides, including their epilepsy-related aspects, has been studied by in vitro and in vivo experiments.</s><s>The results suggest that the antibodies against surface antigens contribute directly to the disease processes.</s><s>This issue has been reviewed by others recently <ref type="bibr" target="#b3">(4)</ref>.</s></p><p><s>Testing for autoantibodies has been incorporated into practical neurology and epilepsy because many tests have been shown to be reliable and specific for distinct phenotypes.</s><s>The key technique for the demonstration of antibodies against the N-methyl-D-aspartate receptor (NMDAR), LGI1, contactin-associated protein-like 2 (CASPR2), the gamma-amino-butyric B receptor (GABA B R), and other surface antigens is the incubation of patient's diluted serum or CSF (undiluted or mildly diluted) with human embryonic kidney (HEK) cells transfected with the antigens of interest.</s><s>Potential antibody binding is then visualized with a "secondary" antibody against human IgG carrying a fluorochrome or other chemicals permitting the detection of a surface staining of the HEK cells under the microscope <ref type="bibr" target="#b4">(5)</ref>.</s></p><p><s>Other techniques include testing for autoantigen binding on rodent brain, immunoblotting, or radioimmunoprecipitation.</s><s>All investigations follow the same principle: binding of autoantibodies to the matrix is detected by an anti-human IgG antibody.</s><s>Formal requirements for making antibody diagnoses are given in Table <ref type="table">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Antibody-Negative Autoimmune Epilepsy</head><p><s>Some patients may have phenotypes typical of autoimmune epilepsy (e.g., an acute, unexplained epilepsy onset with accompanying neuropsychiatric features; elevated cell count or intrathecal IgG synthesis demonstrated by CSF studies; or inflammatory brain lesions according to neuroimaging or his-topathology) in the absence of a known autoantibody despite extensive testing.</s><s>These patients may benefit from immunotherapy <ref type="bibr" target="#b7">(8)</ref>.</s><s>In the absence of a reliable biomarker, it is difficult to gain systematic and general insights into these patients' diseases.</s><s>It can be hoped that detection of novel antibodies or other encephalitis markers will decrease the number of patients in this group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Which Epilepsy Patients Should be Tested, and How?</head><p><s>The answer to this "deontological" question is only in part a biological-medical one.</s><s>It rather depends on how one weighs the costs of the diagnostic evaluations, the likelihood of having a positive result, and the risks of immunotherapies in antibody-positive cases.</s><s>For some of these issues, only limited data are available.</s><s>There are, however, certainly clinical circumstances in which a positive test result is more likely than in others.</s><s>A general suggestion for the identification of autoimmune encephalitides prior to autoantibody diagnostics has recently been published <ref type="bibr" target="#b8">(9)</ref>.</s><s>Features suggestive of autoimmune epilepsies are summarized in Table <ref type="table">2</ref>.</s><s>In recent years, several authors have recommended to test CSF and serum at the same time <ref type="bibr" target="#b10">(11)</ref><ref type="bibr" target="#b11">(12)</ref><ref type="bibr" target="#b12">(13)</ref>.</s><s>They have done so because in some instances, antibodies may not be detectable in both materials, for example, NMDAR antibodies not always in serum ( <ref type="formula">14</ref>) and LGI1 antibodies not always in CSF <ref type="bibr" target="#b11">(12,</ref><ref type="bibr" target="#b14">15)</ref>.</s><s>Exceptions from the general suggestion to test CSF-serum pairs may be young females with an encephalopathic presentation suggestive of anti-NMDAR encephalitis (CSF sufficient) or faciobrachial dystonic seizures (serum for LGI1 antibody testing usually sufficient).</s><s>If the results of those specific tests are negative, there may be need for subsequent more extensive testing.</s></p><p><s>Similarly, the selection of antibodies to be tested for should probably not be too small.</s><s>The phenotypic features of autoimmune epilepsy rarely permit a targeted testing for a specific antibody, except for a typical presentation of anti-NMDAR encephalitis and the faciobrachial dystonic seizures seen with anti-LGI1 antibodies.</s><s>In most other cases, a broader approach should be taken to avoid time consuming and expensive sequential testing for single antibodies.</s><s>One strategy is the use of rodent brain as a "general" assay to select for samples containing any antibody before subtyping it by cell-based assays (taking into account the staining pattern on rodent brain)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TABLE 1. Formal requirements for making antibody diagnoses</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Antibodies</head><p><s>Methods required for making a definite diagnosis "Well-established" onconeural antibodies <ref type="bibr" target="#b5">(6)</ref> and those against Sox1, DNER Demonstration on two independent tests, for example, characteristic staining pattern on rodent brain plus immunoblot positivity <ref type="bibr" target="#b5">(6)</ref> Antibodies against neural surface proteins Cell-based assays: demonstration of antibody binding to HEK cells expressing the antigen of interest in a naturalistic conformation <ref type="bibr" target="#b6">(7)</ref> GAD antibodies Radioimmunoprecipitation, cell-based assay, immunoblot, or enzyme-linked immunosorbent assay as suggested by the Philadelphia and Barcelona groups <ref type="bibr" target="#b15">(16)</ref>.</s></p><p><s>Another approach is the use of multivalent panels of specific tests in form of commercially available mosaics of cell-based assays presenting surface antigens plus multivalent immunoblots with intracellular antigens <ref type="bibr" target="#b16">(17)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>What Does a "Positive Result" Mean?</head><p><s>The clinician is most interested in antibodies with two characteristics: 1) confirmed specificity for distinct syndromes (two criteria fulfilled: the antibodies do not or only exceptionally occur in persons with other or without neurological disease; and, the syndromic specificity has been found in more than one series), and 2) predictive potency for responsiveness to immunologic therapy.</s><s>Using these criteria, not all neural autoantibodies have the same "value.</s><s>" Here, we propose a simple dichotomy of "high-rank antibodies" (reproducibly specific and treatment responsive) and "grey cases" (not fulfilling both criteria) (Table <ref type="table">3</ref>).</s><s>In some cases, the site of antibody detection (blood or CSF) makes the difference between the two categories.</s><s>In the absence of comparative studies across all antibodies, this clas-sification has a certain degree of arbitrariness, and may require refinement with future data.</s></p><p><s>Applying these categories, the percentage of epilepsy patients with "high rank antibodies" in series of patients without encephalitic features is less than 5 percent, with a larger proportion of "grey cases" of less clear specificity <ref type="bibr" target="#b17">(18)</ref><ref type="bibr" target="#b18">(19)</ref><ref type="bibr" target="#b19">(20)</ref><ref type="bibr" target="#b20">(21)</ref>.</s><s>The proportion of positive antibodies goes up with inclusion of patients clinically suggestive of having an encephalitis as a cause of their recurrent seizures, but again, most series contain "grey cases" of unknown significance <ref type="bibr" target="#b21">(22,</ref><ref type="bibr" target="#b22">23)</ref>.</s><s>To conclude, autoimmune epilepsy is rare in the whole epilepsy population unless features of Table <ref type="table">2</ref> are considered.</s><s>In anti-NMDAR encephalitis, monosymptomatic cases account for only 1 percent in the largest available series ("seizures only" being just a part of this fraction) <ref type="bibr" target="#b23">(24)</ref>.</s><s>Even if one concedes some sampling bias in favor of more severely (polysymptomatically) affected patients, this seems to be characteristic for many antibodies.</s><s>In contrast, there may be prolonged disease periods with "seizures only" with LGI1 antibodies (18% <ref type="bibr" target="#b24">[25]</ref>).</s><s>One or more "seizure(s) only" as a presenting symptom are frequent with CASPR2 antibodies (24% <ref type="bibr" target="#b25">[26]</ref> to 72% <ref type="bibr" target="#b26">[27]</ref>) and in male patients with anti-NMDAR</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TABLE 2. Features of patients with seizures and increased likelihood of having autoimmune epilepsy (modified from [10])</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Features</head><p><s>Most likely, antibodies are directed against …</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Syndrome</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limbic encephalitis</head><p><s>LGI1, CASPR2, AMPAR, GABA B R, GlyR, DPPX, GAD65, Hu, Ma, CV2, amphiphysin, Sox1, DNER Faciobrachial dystonic seizures LGI1</s></p><p><s>Encephalopathy (in the sense of a diffuse, multilevel affection of cerebral function) NMDAR, GABA B R, GlyR, DPPX, GABA A R, Neurexin-3α</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient and history</head><p><s>Young females <ref type="bibr">(15-45 y)</ref> NMDAR, GAD</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>History of other autoimmune conditions GAD</head><p><s>Epilepsy onset together with prominent psychiatric or cognitive problems</s></p><p><s>LGI1, CASPR2.</s><s>NMDAR, GlyR, AMPAR, GABA B R, mGluR5, DPPX, GABA A R, Neurexin-3α, GAD, Hu, Ma, CV2, amphiphysin, DNER, Sox1</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Seizure types and patterns</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Unexplained new onset epilepsy in adult life</head><p><s>LGI1, CASPR2.</s><s>NMDAR, GlyR, AMPAR, GABA B R, mGluR5, DPPX, GABA A R, Neurexin-3α, GAD, Hu, Ma, CV2, amphiphysin, DNER, Sox1</s></p><p><s>Onset with status epilepticus or very high seizure frequency NMDAR, LGI1, GABA B R, GABA A R, GAD</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pilomotor seizures</head><p><s>LGI1, Hu, Ma</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Paraclinical findings</head><p><s>EEG: "extreme delta brush" NMDAR CSF: cell count ↑ or unmatched oligoclonal bands</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>All except LGI1 MRI: encephalitic lesion</head><p><s>LGI1, CASPR2, GlyR, AMPAR, GABA B R, mGluR5, DPPX, GABA A R, Neurexin-3α, GAD, Hu, Ma, CV2, amphiphysin, DNER, Sox1</s></p><p><s>Encephalitic histopathology All except NMDAR</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TABLE 3. "High-rank antibodies" versus "grey cases" according to the published case series (N ≥ 10 where available)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Syndrome specificity according to earliest publication</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Refs. Specificity confirmed</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Refs. Improvement upon immunotherapy</head><p><s>Refs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>High-rank antibodies against …</head><p><s>NMDAR in CSF Cognitive and psychiatric problems, seizures, impaired consciousness, abnormal movements</s></p><p><s>LGI1 LE (</s></p><p><s>CASPR2 LE, Morvan syndrome, ataxia (</s></p><p><s>Grey cases: antibodies against …</s></p><p><s>Onconeural, example: anti-Hu* LE</s></p><p><s>encephalitis (27% <ref type="bibr" target="#b27">[28]</ref> to 62% <ref type="bibr" target="#b28">[29]</ref>); in these patients, other CNS symptoms evolved within 1 to 17 days (29, 27) emphasizing again the importance of antibody testing especially in patients with complex phenotypes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Which Treatment to Choose?</head><p><s>The conditions associated with antibodies against surface antigens often have a favorable prognosis with immunotherapy.</s></p><p><s>From an epilepsy standpoint, this is particularly striking with FBDS.</s><s>They hardly respond to antiepileptic drugs, and these medications surprisingly often cause allergic reactions in this condition.</s><s>On the other hand, FBDS respond well to steroids <ref type="bibr" target="#b55">(55)</ref>.</s><s>In the absence of prospective, let alone randomized trials, therapeutic recommendations have relied on retrospective evaluations.</s><s>The most influential one comes from the experience in anti-NMDAR encephalitis <ref type="bibr" target="#b56">(56)</ref>, which suggested the sequence of first line therapies (steroids, intravenous immunoglobulin, or apheresis therapy-or combinations of these interventions) and second line therapies (cyclophosphamide and/ or rituximab).</s><s>There are no evidence-based dosing recommendations.</s><s>Recently, rituximab <ref type="bibr" target="#b57">(57,</ref><ref type="bibr" target="#b58">58)</ref> and apheresis techniques <ref type="bibr" target="#b59">(59,</ref><ref type="bibr" target="#b60">60)</ref> have received increasing attention.</s><s>It is to be expected that local preferences, individual patient features (i.e., special risk situations), reimbursement issues, and personal experience of treating physicians will influence the therapeutic sequence.</s><s>A suggested sequence of interventions in cases with "high-rank antibodies" is given in Figure <ref type="figure" target="#fig_1">2</ref>. In addition to prednisolone, an apheresis technique may be used to Where no material is mentioned, any positivity-in serum or CSF-is sufficient.</s><s>In the references columns, in some cases, only a selection of references is given.</s><s>Abbreviations: Refs., references; +, yes fulfilled; LE, limbic encephalitis; +/−, partly fulfilled; PERM, progressive encephalomyelitis with rigidity and myoclonus; −, no not fulfilled; TLE, temporal lobe epilepsy; SMS, stiff-man syndrome; n.s.a., no series available; ?, questionable, no unequivocal results.</s><s>*Please note that a special value of these antibodies is that they predict an underlying neoplastic disorder in the vast majority of cases <ref type="bibr" target="#b52">(52)</ref>.</s><s>†Please note that there are divergent results on the precise antigenic specificity within the GABA A receptor <ref type="bibr" target="#b48">(48,</ref><ref type="bibr" target="#b53">53,</ref><ref type="bibr" target="#b54">54)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TABLE 3. Continued</head><p><s>reduce the antibody burden rapidly.</s><s>Prior to the oral prednisolone, a course of three to five pulses of 500-to 1000-mg methylprednisolone may be given on consecutive days.</s><s>For the "grey cases, " a similar approach has been suggested recently <ref type="bibr" target="#b7">(8)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Summary, Final Remarks</head><p><s>Autoimmunity by antibodies is causative for a small proportion of epilepsies.</s><s>The identification of such cases is, nevertheless, of importance because many of the affected patients have a favorable prognosis with immunotherapy.</s><s>Neural autoantibodies can be specifically diagnosed by established techniques.</s><s>Clinical challenges include identifying which patients should undergo antibody testing and delineating the most appropriate therapeutic interventions.</s><s>Preliminary, readily applicable suggestions exist, and will continue to be refined with increased knowledge over time.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of interest</head><p><s>CGB gave scientific advice to Eisai (Frankfurt, Germany) and UCB (Monheim, Germany), undertook industry-funded travel with support of Eisai (Frankfurt, Germany), UCB (Monheim, Germany), Desitin (Hamburg, Germany), and Grifols (Frankfurt, Germany), obtained honoraria for speaking engagements from Eisai (Frankfurt, Germany), UCB (Monheim, Germany), Desitin (Hamburg, Germany), diamed (Köln, Germany), Fresenius Medical Care (Bad Homburg, Germany), and Biogen (Ismaning, Germany).</s><s>He received research support from diamed (Köln, Germany) and Fresenius Medical Care (Bad Homburg, Germany).</s><s>He is a consultant to the Laboratory Krone, Bad Salzuflen, Germany, regarding neural antibodies and therapeutic drug monitoring for antiepileptic drugs.</s></p><p><s>MH received speaker's honoraria and/or consultancy fees from Cyberonics, Desitin, Eisai, GlaxoSmithKline, Janssen-Cilag, Novartis, UCB and Viropharma.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Autoantigens in autoimmune encephalitides with seizures.</s></p></div></figDesc><graphic coords="2,58.14,85.85,482.22,206.92" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Suggestion for a treatment pathway in patients with "high-rank antibodies.</s><s>" This treatment pathway is used in the author's (CGB) institution.</s><s>It is based on previous recommendations (56).</s></p></div></figDesc><graphic coords="5,54.00,397.38,484.18,297.62" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Autoimmune epilepsies</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="146" to="153" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Immunotherapy-responsive seizure-like episodes with potassium channel antibodies</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Buckley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">C</forename><surname>Cockerell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rudge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="1647" to="1648" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Michell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pettingill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bleasel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Somerville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="892" to="900" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Paving the way to understand autoantibody-mediated epilepsy on the molecular level</title>
		<author>
			<persName><forename type="first">G</forename><surname>Seebohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Piccini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Strutz-Seebohm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Neurol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">149</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tüzün</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Masjuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Voloschin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Baehring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shimazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Koide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Sansing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Dichter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Lynch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="25" to="36" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Recommended diagnostic criteria for paraneoplastic neurological syndromes</title>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Antoine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Giometto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Grisold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Honnorat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sillevis</forename><surname>Smitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vedeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Verschuuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Voltz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="1135" to="1140" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Detection and characterization of autoantibodies to neuronal cell-surface antigens in the central nervous system</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Van Coevorden-Hameete</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Schreurs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>De Graaff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sillevis</forename><surname>Smitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Hoogenraad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Mol Neurosci</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">37</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Byun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Sunwoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1683" to="1691" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">A clinical approach to diagnosis of autoimmune encephalitis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Benseler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cellucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cortese</forename><forename type="middle">I</forename><surname>Dale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Gelfand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Geschwind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Glaser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Honnorat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hoftberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Iizuka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Lancaster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Leypoldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pruss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Rae-Grant</forename></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reindl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rostasy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Saiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Venkatesan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wandinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="391" to="404" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Value of autoantibodies for prediction of treatment response in patients with autoimmune epilepsy: review of the literature and suggestions for clinical management</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epilepsia</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="48" to="55" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">NMDAR encephalitis: which specimens, and the value of values</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mckeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Lennon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="133" to="135" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Autoimmune encephalopathies</title>
		<author>
			<persName><forename type="first">F</forename><surname>Leypoldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Armangue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1338</biblScope>
			<biblScope unit="page" from="94" to="114" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Anti-AMPA receptor encephalitis: the family of glutamatergic autoencephalitides further expands</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Panzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Dale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="2390" to="2391" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study</title>
		<author>
			<persName><forename type="first">N</forename><surname>Gresa-Arribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Torrents</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Aguilar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mccracken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leypoldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Gleichman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balice-Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="167" to="177" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Autoimmune encephalitis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Leypoldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Wandinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Neurol Rev</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="31" to="37" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies</title>
		<author>
			<persName><forename type="first">R</forename><surname>Höftberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Neuropathol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="337" to="341" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Seroprevalence of autoantibodies against brain antigens in health and disease</title>
		<author>
			<persName><forename type="first">L</forename><surname>Dahm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Stepniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Teegen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saschenbrecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Borowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Begemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lemke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rentzsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Probst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Martens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wienands</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Spalletta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Weissenborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Stocker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ehrenreich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="82" to="94" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy</title>
		<author>
			<persName><forename type="first">T</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Sills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Howell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Brodie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epilepsia</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1028" to="1035" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Autoimmune epilepsy in children: case series and proposed guidelines for identification</title>
		<author>
			<persName><forename type="first">J</forename><surname>Suleiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Brilot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Dale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epilepsia</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1036" to="1045" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Investigation of neuronal autoantibodies in two different focal epilepsy syndromes</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ekizoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tuzun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Woodhall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Icoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bebek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gurses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gokyigit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Baykan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epilepsia</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="414" to="422" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Autoantibodies to neuronal antigens in children with focal epilepsy and no prima facie signs of encephalitis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Borusiak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Bettendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wiegand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kluger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Philippi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Munstermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Paediatr Neurol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="573" to="579" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Hacohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agrawal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Sousa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Devile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fallon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hedderly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lascelles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Philip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Prabahkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hemingway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wassmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="748" to="755" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Epilepsy and autoimmunity in pediatric patients</title>
		<author>
			<persName><forename type="first">O</forename><surname>Bektas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tutkak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Karagol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Clover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Deda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropediatrics</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="13" to="19" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mccracken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gabilondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Armangue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Glaser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Iizuka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Honig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Benseler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kawachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Aguilar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gresa-Arribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ryan-Florance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Torrents</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balice-Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="157" to="165" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Anti-LGI1-associated cognitive impairment: presentation and long-term outcome</title>
		<author>
			<persName><forename type="first">H</forename><surname>Arino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Armangue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Petit-Pedrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sabater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lancaster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="759" to="765" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The clinical spectrum of Caspr2 antibody-associated disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Van Sonderen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Arino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Petit-Pedrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leypoldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kortvelyessy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Wandinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lancaster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Wirtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Schreurs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sillevis</forename><surname>Smitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="521" to="528" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures</title>
		<author>
			<persName><forename type="first">B</forename><surname>Joubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saint-Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Noraz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Picard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Rogemond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ducray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Desestret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Psimaras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Antoine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Honnorat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Neurol</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="1115" to="1124" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="550" to="551" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Viaccoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Desestret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ducray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Picard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cavillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Rogemond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Antoine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Honnorat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="556" to="563" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan&apos;s syndrome and acquired neuromyotonia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kleopa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pettingill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zuliani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Peles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Buckley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="2734" to="2748" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Huijbers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lancaster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bataller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balice-Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Cowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="776" to="785" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lancaster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Huijbers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boronat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bataller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Illa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Markx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Strauss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Peles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Scherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="303" to="311" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Contactinassociated protein-2 antibodies in non-paraneoplastic cerebellar ataxia</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zuliani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pettingill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dulneva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sobott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wardle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bataller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="437" to="440" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title level="m" type="main">Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Mirzadjanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Baumgartner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dogan</forename><surname>Onugoren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grunwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Holtkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Isenmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kermer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Melzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Naumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Riepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schäbitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Von Oertzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Podewils</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>May</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2016-10-27">October 27. 2016</date>
		</imprint>
	</monogr>
	<note>published onlines ahead of print</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title/>
		<idno type="DOI">10.1111/ene.13180</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Neurol</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Contactin-Associated Protein-like 2 Antibodies: Tackling the Issue of Syndrome Diversity</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Neurol</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="1058" to="1059" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Encephalitis and antibodies to dipeptidylpeptidase-like protein-6, a subunit of Kv4.2 potassium channels</title>
		<author>
			<persName><forename type="first">A</forename><surname>Boronat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gelfand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gresa-Arribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Jeong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balice-Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rudy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="120" to="128" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Limbic encephalitis and small cell lung cancer. Clinical and immunological features</title>
		<author>
			<persName><forename type="first">S</forename><surname>Alamowitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Uchuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rene</forename><forename type="middle">R</forename><surname>Bescansa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="923" to="928" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients</title>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Keime-Guibert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rene</forename><forename type="middle">R</forename><surname>Benyahia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ribalta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ascaso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Escaramis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="1138" to="1148" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy</title>
		<author>
			<persName><forename type="first">Sillevis</forename><surname>Smitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grefkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Leeuw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Van Den</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Van Putten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hooijkaas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Vecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol</title>
		<imprint>
			<biblScope unit="volume">249</biblScope>
			<biblScope unit="page" from="745" to="753" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone</title>
		<author>
			<persName><forename type="first">F</forename><surname>Keime-Guibert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fleury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Honnorat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Broet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Delattre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="479" to="482" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Liimatainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peltola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sabater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fallah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kharazmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Haapala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dastidar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Knip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peltola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epilepsia</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="760" to="767" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Butler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Solimena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dirkx</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hayday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Camilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="2097" to="2106" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association</title>
		<author>
			<persName><forename type="first">A</forename><surname>Saiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sabater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gonzalez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bataller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Casamitjana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ramio-Torrenta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="2553" to="2563" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Malter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Helmstaedter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Urbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="470" to="478" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Malter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Frisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zeitler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Surges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Urbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Helmstaedter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Elger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Seizure</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="57" to="63" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lancaster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Antoine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Liebers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kornblum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Honnorat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Contractor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balice-Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="1698" to="1701" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Van Sonderen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Schreurs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>De Bruijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boukhrissi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Nagtzaam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Hulsenboom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Enting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Thijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Wirtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sillevis</forename><surname>Smitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1692" to="1699" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization</title>
		<author>
			<persName><forename type="first">P</forename><surname>Pettingill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Coebergh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pettingill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Maxwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nibber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Malaspina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jacob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Buckley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Beeson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="1233" to="1241" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Carvajal-Gonzalez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Leite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Woodhall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Coutinho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Balint</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pettingill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">M</forename><surname>Sheerin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Press</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Lunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Maddison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Meinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Vandenberghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="2178" to="2192" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Human neurexin-3a antibodies associate with encephalitis and alter synapse development</title>
		<author>
			<persName><forename type="first">N</forename><surname>Gresa-Arribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Planaguma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Petit-Pedrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kawachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Katada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Glaser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Simabukuro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Armangue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="2235" to="2242" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schulze-Bonhage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Deckert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Urbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Helmstaedter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Grunwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schaller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Elger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1823" to="1828" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Paraneoplastic syndromes of the CNS</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rosenfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="327" to="340" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ohkawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Satake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yokoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Miyazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ohshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sobue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fukata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="8151" to="8163" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Petit-Pedrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Armangue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bataller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cellucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mccracken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Kruer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Ritacco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Grisold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Meaney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alcala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sillevis-Smitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Titulaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balice-Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="276" to="286" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Stagg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Rosenthal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pettingill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pettingill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Voets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cardoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Cash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Manning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="3151" to="3162" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lancaster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balice-Gordon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="63" to="74" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ishiura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Higashihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hanajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalmau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tsuji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="1921" to="1923" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gelfand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Bettcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Singhal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Geschwind</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Neurol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="896" to="900" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-n-methyl-daspartate receptor antibody encephalitis: a retrospective review</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Desena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Noland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matevosyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Qureshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Graves</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Apher</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="212" to="216" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Immunoadsorption therapy in autoimmune encephalitides</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dogan Onugoren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Golombeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abu-Tair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bulla-Hellwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lohmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Munstermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pavenstadt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tholking</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Valentin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wiendl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Melzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurol Neuroimmunol Neuroinflamm</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e207</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
